Delayed Choroidal Neovascular Membrane After Unilateral Acute Idiopathic Maculopathy.

IF 1.7 4区 医学 Q2 OPHTHALMOLOGY
Ocular Immunology and Inflammation Pub Date : 2026-09-01 Epub Date: 2026-07-13 DOI:10.1080/09273948.2026.2703623
Prathiba Hande, Vighnesh Shetty, Shreya Angrish, Anisha Vyawahare, Vishma Prabhu, Ramesh Venkatesh
{"title":"Delayed Choroidal Neovascular Membrane After Unilateral Acute Idiopathic Maculopathy.","authors":"Prathiba Hande, Vighnesh Shetty, Shreya Angrish, Anisha Vyawahare, Vishma Prabhu, Ramesh Venkatesh","doi":"10.1080/09273948.2026.2703623","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of delayed choroidal neovascular membrane (CNVM) following unilateral acute idiopathic maculopathy (UAIM) and to highlight the potential role of persistent choriocapillaris dysfunction and inflammation in its pathogenesis and management.</p><p><strong>Methods: </strong>A 22-year-old woman with a previous history of steroid-responsive UAIM presented 9 months later with reduced vision (6/30) in the same eye. Multimodal imaging, including optical coherence tomography (OCT), OCT angiography (OCTA), fluorescein angiography (FFA), and indocyanine green angiography (ICGA), was performed to characterize the lesion. A subfoveal CNVM was identified and initially treated with intravitreal faricimab. Owing to persistent vascular activity and the subsequent development of adjacent inflammatory lesions, systemic corticosteroids were added in combination with further anti-VEGF therapy.</p><p><strong>Result: </strong>Initial anti-VEGF therapy reduced exudation but failed to achieve complete disease control. Following combined anti-VEGF and systemic corticosteroid therapy, both the inflammatory lesions and CNVM activity regressed. At final follow-up, exudation had resolved, OCTA demonstrated a compact mature vascular network without evidence of active neovascularization, and best-corrected visual acuity improved from 6/30 to 6/12.</p><p><strong>Conclusion: </strong>CNVM may develop as a delayed complication of UAIM despite apparent structural recovery. Persistent choriocapillaris hypoperfusion and recurrent inflammation may contribute to its development, although a causal relationship remains to be established. This case highlights the value of multimodal imaging in identifying the underlying mechanisms of delayed CNVM and suggests that combined anti-VEGF and anti-inflammatory therapy may be beneficial in selected patients. Long-term surveillance is warranted in eyes with UAIM.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":" ","pages":"1585-1589"},"PeriodicalIF":1.7000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2026.2703623","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To report a case of delayed choroidal neovascular membrane (CNVM) following unilateral acute idiopathic maculopathy (UAIM) and to highlight the potential role of persistent choriocapillaris dysfunction and inflammation in its pathogenesis and management.

Methods: A 22-year-old woman with a previous history of steroid-responsive UAIM presented 9 months later with reduced vision (6/30) in the same eye. Multimodal imaging, including optical coherence tomography (OCT), OCT angiography (OCTA), fluorescein angiography (FFA), and indocyanine green angiography (ICGA), was performed to characterize the lesion. A subfoveal CNVM was identified and initially treated with intravitreal faricimab. Owing to persistent vascular activity and the subsequent development of adjacent inflammatory lesions, systemic corticosteroids were added in combination with further anti-VEGF therapy.

Result: Initial anti-VEGF therapy reduced exudation but failed to achieve complete disease control. Following combined anti-VEGF and systemic corticosteroid therapy, both the inflammatory lesions and CNVM activity regressed. At final follow-up, exudation had resolved, OCTA demonstrated a compact mature vascular network without evidence of active neovascularization, and best-corrected visual acuity improved from 6/30 to 6/12.

Conclusion: CNVM may develop as a delayed complication of UAIM despite apparent structural recovery. Persistent choriocapillaris hypoperfusion and recurrent inflammation may contribute to its development, although a causal relationship remains to be established. This case highlights the value of multimodal imaging in identifying the underlying mechanisms of delayed CNVM and suggests that combined anti-VEGF and anti-inflammatory therapy may be beneficial in selected patients. Long-term surveillance is warranted in eyes with UAIM.

单侧急性特发性黄斑病变后迟发性脉络膜新生血管膜。
目的:报告一例单侧急性特发性黄斑病变(UAIM)后迟发性脉络膜新生血管膜(CNVM),并强调持续性脉络膜毛细血管功能障碍和炎症在其发病机制和治疗中的潜在作用。方法:22岁女性,既往有类固醇反应性UAIM病史,9个月后出现同眼视力下降(6/30)。采用多模态成像,包括光学相干断层扫描(OCT)、OCT血管造影(OCTA)、荧光素血管造影(FFA)和吲哚菁绿血管造影(ICGA)来表征病变。发现了中央凹下CNVM,并最初使用玻璃体内法利西单抗治疗。由于持续的血管活动和随后的邻近炎性病变的发展,全身性皮质类固醇与进一步的抗vegf治疗联合使用。结果:最初的抗vegf治疗减少了渗出,但未能完全控制疾病。在联合抗vegf和全身皮质类固醇治疗后,炎性病变和CNVM活性均有所消退。在最后的随访中,渗出已经消失,OCTA显示一个紧凑的成熟血管网络,没有活跃的新血管形成的证据,最佳矫正视力从6/30提高到6/12。结论:尽管有明显的结构恢复,但CNVM可能发展为UAIM的延迟并发症。持续的绒毛毛细血管灌注不足和复发性炎症可能有助于其发展,尽管因果关系仍有待确定。该病例强调了多模态成像在识别延迟性CNVM的潜在机制方面的价值,并表明联合抗vegf和抗炎治疗可能对特定患者有益。在UAIM的眼睛中进行长期监视是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书